Grace Therapeutics (GRCE) Prepaid Assets (2017 - 2026)
Grace Therapeutics (GRCE) posted Prepaid Assets of $383000.0 for Q1 2026, down 26.2% sequentially from $519000.0 in Q4 2025, and down 15.45% YoY from $453000.0 in Q1 2025.
Grace Therapeutics (GRCE) Prepaid Assets (2017 - 2026) Analysis & Trends
Grace Therapeutics has reported Prepaid Assets for 10 years, with the latest figure at $383000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 15.45% year-over-year to $383000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $383000.0 (down 15.45% YoY) and the FY2026 annual result came in at $383000.0, down 15.45% from the prior year.
- Prepaid Assets eased to $383000.0 in Q1 2026 per GRCE's latest filing, from $519000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.5 million in Q2 2022 and troughed at $283000.0 in Q1 2024.
- A 5-year average of $733588.2 and a median of $598000.0 in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets jumped 109.91% in 2022, then tumbled 54.31% in 2024.
- Over 5 years, Prepaid Assets stood at $1.0 million in 2022, then fell by 22.17% to $811000.0 in 2023, then retreated by 28.11% to $583000.0 in 2024, then declined by 10.98% to $519000.0 in 2025, then dropped by 26.2% to $383000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $383000.0, $519000.0, and $416000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Grace Therapeutics | 37.04 Mn | 37.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 557,000.00 |
| Mar 31, 2026 | 383,000.00 |
| Dec 31, 2025 | 519,000.00 |
| Sep 30, 2025 | 416,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 453,000.00 |
| Dec 31, 2024 | 583,000.00 |
| Sep 30, 2024 | 477,000.00 |
| Jun 30, 2024 | 622,000.00 |
| Mar 31, 2024 | 283,000.00 |
| Dec 31, 2023 | 811,000.00 |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 598,000.00 |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 1.54 Mn |
| Mar 31, 2022 | 720,000.00 |
| Dec 31, 2021 | 1.85 Mn |
| Sep 30, 2021 | 2.18 Mn |